ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test sale cost 4400 AED
COL4A6 Gene Deafness X-Linked Type 6 Genetic Test sale cost 4400 AED COL4A6 Gene Deafness X-Linked Type 6 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test sale cost 4400 AED DNAH9 Gene Primary Ciliary Dyskinesia DNAH9 Related Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test is a specialized diagnostic examination conducted to identify mutations in the ARMC4 gene, which are associated with Primary Ciliary Dyskinesia (PCD) Type 23. PCD is a rare genetic disorder characterized by chronic respiratory tract infections, abnormal organ positioning, and fertility issues, stemming from defects in the structure and function of cilia. The ARMC4 gene plays a crucial role in the development and function of cilia, and mutations in this gene can lead to the manifestation of PCD symptoms.

This genetic test is vital for individuals showing symptoms of PCD or those with a family history of the condition, as it can provide a definitive diagnosis. By pinpointing the specific mutation within the ARMC4 gene, healthcare providers can better understand the condition’s progression, tailor treatments to manage symptoms more effectively, and offer genetic counseling for affected families.

The test is available at DNA Labs UAE, a leading facility in genetic diagnostics and research. The cost of the ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test is 4400 AED. Conducting the test in such a specialized lab ensures accuracy and reliability in the results, offering crucial information for managing and understanding this rare genetic disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test

At DNA Labs UAE, we offer the ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test. This test is designed to detect mutations in the ARMC4 gene, which is associated with primary ciliary dyskinesia type 23.

Test Components

  • Price: 4400.0 AED

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on an FTA card for this test.

Report Delivery

Reports are typically delivered within 3 to 4 weeks.

Method

We use NGS (Next-Generation Sequencing) technology for this test.

Test Type

This test is specifically designed for Ear Nose Throat Disorders.

Doctor

Our ENT Doctor will oversee the testing process.

Test Department

This test is conducted in our Genetics department.

Pre Test Information

Before undergoing the ARMC4 Gene Primary Ciliary Dyskinesia Type 23 Genetic Test, it is important to provide the clinical history of the patient. This test is recommended for individuals who exhibit symptoms such as cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by these symptoms.

Test Details

The ARMC4 gene is responsible for primary ciliary dyskinesia type 23, a genetic disorder that affects the function of cilia in the body. Cilia are hair-like structures found on the surface of cells and are involved in various bodily functions, including the movement of mucus and fluids in the respiratory tract, reproductive system, and other organs.

Primary ciliary dyskinesia (PCD) is characterized by impaired ciliary function, leading to chronic respiratory infections, sinus problems, and infertility. PCD type 23 specifically occurs due to mutations in the ARMC4 gene.

NGS genetic testing is a method that allows for the identification of genetic variations and mutations in an individual’s DNA. This advanced technology enables the simultaneous analysis of multiple genes, providing a comprehensive view of an individual’s genetic makeup.

In the case of PCD type 23, NGS genetic testing can be used to identify mutations in the ARMC4 gene. This helps in confirming a diagnosis and guiding treatment decisions.

If you suspect that you or someone you know may have primary ciliary dyskinesia type 23, we recommend consulting with a healthcare professional or a genetic counselor. They can provide further information and guidance regarding genetic testing options.

Test Name ARMC4 Gene Primary ciliary dyskinesia type 23 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS18
Test Details

The ARMC4 gene is associated with primary ciliary dyskinesia type 23, a genetic disorder that affects the function of cilia in the body. Cilia are hair-like structures found on the surface of cells and play a crucial role in various bodily functions, including the movement of mucus and fluids in the respiratory tract, reproductive system, and other organs.

Primary ciliary dyskinesia (PCD) is characterized by impaired ciliary function, leading to chronic respiratory infections, sinus problems, and infertility. PCD type 23 is specifically caused by mutations in the ARMC4 gene.

NGS (Next-Generation Sequencing) genetic testing is a method used to identify genetic variations and mutations in an individual’s DNA. It allows for the simultaneous analysis of multiple genes, providing a comprehensive view of an individual’s genetic makeup. In the context of PCD type 23, NGS genetic testing can be used to identify mutations in the ARMC4 gene, helping to confirm a diagnosis and guide treatment decisions.

If you suspect you or someone you know may have primary ciliary dyskinesia type 23, it is recommended to consult with a healthcare professional or a genetic counselor who can provide further information and guidance regarding genetic testing options.

SKU: TEST-2779 Category:

Related products